IL122845A0 - Use of unsubstituted and substituted N- (pyrrol-1-yl) pyridinamines as anticonvulsant agents - Google Patents

Use of unsubstituted and substituted N- (pyrrol-1-yl) pyridinamines as anticonvulsant agents

Info

Publication number
IL122845A0
IL122845A0 IL12284596A IL12284596A IL122845A0 IL 122845 A0 IL122845 A0 IL 122845A0 IL 12284596 A IL12284596 A IL 12284596A IL 12284596 A IL12284596 A IL 12284596A IL 122845 A0 IL122845 A0 IL 122845A0
Authority
IL
Israel
Prior art keywords
pyridinamines
pyrrol
unsubstituted
substituted
anticonvulsant agents
Prior art date
Application number
IL12284596A
Other languages
English (en)
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Priority to IL15152196A priority Critical patent/IL151521A/en
Publication of IL122845A0 publication Critical patent/IL122845A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL12284596A 1995-07-27 1996-07-08 Use of unsubstituted and substituted N- (pyrrol-1-yl) pyridinamines as anticonvulsant agents IL122845A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL15152196A IL151521A (en) 1995-07-27 1996-07-08 Use of unsubstituted and substituted n-(pyrrol-1-yl) pyridinamines in the preparation of anticonvulsant pharmaceutical compositions, and pharmaceutical compositions comprising them

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50807195A 1995-07-27 1995-07-27
PCT/US1996/011408 WO1997004777A1 (en) 1995-07-27 1996-07-08 Use off unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents

Publications (1)

Publication Number Publication Date
IL122845A0 true IL122845A0 (en) 1998-08-16

Family

ID=24021262

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12284596A IL122845A0 (en) 1995-07-27 1996-07-08 Use of unsubstituted and substituted N- (pyrrol-1-yl) pyridinamines as anticonvulsant agents

Country Status (19)

Country Link
EP (1) EP0840609B1 (de)
JP (1) JP4189029B2 (de)
KR (1) KR100445629B1 (de)
CN (1) CN1184969C (de)
AR (1) AR003471A1 (de)
AT (1) ATE218343T1 (de)
AU (1) AU696007B2 (de)
CA (1) CA2225156C (de)
DE (1) DE69621617T2 (de)
DK (1) DK0840609T3 (de)
ES (1) ES2174081T3 (de)
IL (1) IL122845A0 (de)
MX (1) MX9800774A (de)
NO (1) NO315148B1 (de)
NZ (1) NZ312577A (de)
PT (1) PT840609E (de)
TW (1) TW464497B (de)
WO (1) WO1997004777A1 (de)
ZA (1) ZA966254B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT200500063A (es) * 2004-04-01 2005-10-14 Metodo para tratar la esquizofrenia y/o anormalidades glucoregulatorias
FR2897614B1 (fr) * 2006-02-20 2008-05-23 Urogene Forme cristalline du chlorhydrate de la besipirdine, procedes de preparation et utilisations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032599A (en) * 1986-11-12 1991-07-16 Hoechst-Roussel Pharmaceuticals Inc. N-(pyrrol-l-yl)pyridinamines
EP0287982B1 (de) * 1987-04-24 1994-12-07 Hoechst-Roussel Pharmaceuticals Incorporated N-(Pyridinyl)-1H-indol-1-amine, Verfahren zu deren Herstellung und ihre Verwendung als Arzneimittel
US4868190A (en) * 1988-12-27 1989-09-19 Hoechst-Roussel Pharmaceuticals, Inc. N-pyridinyl-9H-carbazol-9-amines
US5179099A (en) * 1989-08-02 1993-01-12 Hoechst-Roussel Pharmaceuticals Incorporated 2,3-dihydro-1-(pyridinylamino)-indoles
US5356910A (en) * 1993-07-19 1994-10-18 Hoechst-Roussel Pharmaceuticals Inc. Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder

Also Published As

Publication number Publication date
WO1997004777A1 (en) 1997-02-13
AU696007B2 (en) 1998-08-27
CA2225156C (en) 2003-06-10
KR100445629B1 (ko) 2004-10-14
ES2174081T3 (es) 2002-11-01
KR19990035973A (ko) 1999-05-25
NZ312577A (en) 1999-08-30
HK1015687A1 (en) 1999-10-22
NO980334D0 (no) 1998-01-26
NO315148B1 (no) 2003-07-21
AU6454796A (en) 1997-02-26
CN1191486A (zh) 1998-08-26
JPH11510159A (ja) 1999-09-07
JP4189029B2 (ja) 2008-12-03
ZA966254B (en) 1997-02-11
EP0840609A1 (de) 1998-05-13
CA2225156A1 (en) 1997-02-13
PT840609E (pt) 2002-10-31
DE69621617D1 (de) 2002-07-11
MX9800774A (es) 1998-04-30
NO980334L (no) 1998-03-26
DE69621617T2 (de) 2003-01-02
TW464497B (en) 2001-11-21
ATE218343T1 (de) 2002-06-15
AR003471A1 (es) 1998-08-05
DK0840609T3 (da) 2002-09-30
EP0840609B1 (de) 2002-06-05
CN1184969C (zh) 2005-01-19

Similar Documents

Publication Publication Date Title
HU9601475D0 (en) Substituted n-(indolo-2-carbonyl)-glycinamides and derivatives as antidiabetic agents
HRP960266B1 (en) Substituted n-(indole-2-carbonyl-)amides and derivatives as antidiabetic agents
PL339091A1 (en) Combinet treatment by means of atorvastatin and hypotension agent
GR3036881T3 (en) Benzamide derivatives and their use as vasopressin antagonists
GR3029893T3 (en) N-(Benzofuranazyl)-arylsulphonamides and their analogues useful as endothelin-receptor-antagonists
SI1445259T1 (sl) Uporaba kristalnih oblik 2-metil-tienobenzodiazepina
GB9526560D0 (en) Use of 2-Amino-Heterocycles
SG91796A1 (en) N-(4-aryl-thiazol-2-yl)-sulphonamide derivatives and their use
IL122607A0 (en) Preparation of N-substituted 3-hydroxypyrazoles
ZA957113B (en) Use of N-substituted pyhenothiazines
EG21286A (en) Blends of organosillane compounds and their use
HUP9600227A3 (en) Use of amides of phenyl-cyclohexyl-carboxylic acids
HU9700071D0 (en) Use of muramilpeptides
IL113992A0 (en) Use of copolymer-1
HUP9800146A3 (en) Thalidomide-derivatives and use of them
AU1170995A (en) Pyridil ethylation of lactams
IL122845A0 (en) Use of unsubstituted and substituted N- (pyrrol-1-yl) pyridinamines as anticonvulsant agents
PL341599A1 (en) Novel derivatives of p-aminophenol and their application
IL118629A0 (en) N-Substituted cis-N-propenyl-acetemides their preparation and use
SI0840609T1 (en) Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents
PL314638A1 (en) Novel ethyloamidofluorenes and pharmaceutic agent
AU5841696A (en) Preparation and use of contrast agents
HUP9802413A3 (en) Use of n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents and for the preparation of a pharmaceutical composition for the treatment of convulsions
IL151521A0 (en) Use of unsubstituted and substituted n-(pyrrol-1-yl) pyridinamines in the preparation of anticonvulsant pharmaceutical compositions, and pharmaceutical compositions comprising them
AU2029595A (en) Direct neutralization of N-acyl sarcosines

Legal Events

Date Code Title Description
ERR Corrigendum

Free format text: JOURNAL 12/2003 P. 3366 PATENT APPLICATION NO. 122845 CORRECT TITLE OF INVENTION TO:

FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees